Angiotensin Receptor Blocker/Neprilysin Inhibitor
Combination Blood Pressure Therapy for High Blood Pressure
Recruiting3 awardsPhase 4
Nashville, Tennessee
This trial is testing if a two-drug combination can increase blood flow more than one of the drugs can on its own, and if a third drug can interact with the first two to also increase blood flow.
Angiotensin II Receptor Blocker, COX-2 Inhibitor, Biguanide
Valsartan + Celecoxib + Metformin for Type 2 Diabetes
Recruiting3 awardsPhase 1 & 2
Albany, New York
This trial is evaluating the safety, tolerability and superiority of RK-01, a valsartan plus celecoxib dual add-on to metformin-HCL XR over metformin in newly diagnosed and obese adult type 2 diabetes patients with high blood pressure, arthritis and inadequate glycemic control with metformin monotherapy, diet and exercise. The objective is to assess the effect of RK-01 on hemoglobin A1c (HbA1c) levels, beta cell function and insulin resistance with co-administration of valsartan, celecoxib and metformin-HCl X
Popular Filters
Trials for High Blood Pressure Patients
Vascular Function in Pulmonary Arterial Hypertension
Recruiting2 awardsPhase 1
Salt Lake City, Utah
This trial is designed to study changes in vascular function with advancing age, and also examine peripheral vascular changes in patients suffering from chronic obstructive pulmonary disease (COPD), Sepsis, Pulmonary Hypertension, and cardiovascular disease.
Device
Renal Denervation for High Blood Pressure
Recruiting1 awardPhase 3
Birmingham, Alabama
This trial is testing whether a treatment called renal denervation can help lower blood pressure in people who have uncontrolled hypertension. The trial will compare people who receive the treatment to those who don't, and will be conducted via central randomization.
Trials for HBP Patients
Vascular Function in Pulmonary Arterial Hypertension
Recruiting2 awardsPhase 1
Salt Lake City, Utah
This trial is designed to study changes in vascular function with advancing age, and also examine peripheral vascular changes in patients suffering from chronic obstructive pulmonary disease (COPD), Sepsis, Pulmonary Hypertension, and cardiovascular disease.
Device
Renal Denervation for High Blood Pressure
Recruiting1 awardPhase 3
Birmingham, Alabama
This trial is testing whether a treatment called renal denervation can help lower blood pressure in people who have uncontrolled hypertension. The trial will compare people who receive the treatment to those who don't, and will be conducted via central randomization.
Phase 3 Trials
Endothelin Receptor Antagonist
Macitentan for Pulmonary Hypertension
Recruiting2 awardsPhase 3
Phoenix, Arizona
This trial is testing macitentan, a drug that helps lower lung blood pressure, in children with pulmonary arterial hypertension. Macitentan has shown significant effectiveness in improving the condition of patients with pulmonary arterial hypertension.
Device
Renal Denervation for High Blood Pressure
Recruiting1 awardPhase 3
Birmingham, Alabama
This trial is testing whether a treatment called renal denervation can help lower blood pressure in people who have uncontrolled hypertension. The trial will compare people who receive the treatment to those who don't, and will be conducted via central randomization.
Prostacyclin Receptor Agonist
Ralinepag for Pulmonary Arterial Hypertension
Recruiting1 awardPhase 3
Birmingham, Alabama
This trial is testing ralinepag, a medication being developed for the treatment of pulmonary arterial hypertension (PAH). It aims to see if adding ralinepag to their usual treatments can improve their condition. The medication works by relaxing and opening up the blood vessels in the lungs, which can lower the pressure and improve blood flow.
Trials With No Placebo
Vascular Function in Pulmonary Arterial Hypertension
Recruiting2 awardsPhase 1
Salt Lake City, Utah
This trial is designed to study changes in vascular function with advancing age, and also examine peripheral vascular changes in patients suffering from chronic obstructive pulmonary disease (COPD), Sepsis, Pulmonary Hypertension, and cardiovascular disease.
Endothelin Receptor Antagonist
Macitentan for Pulmonary Hypertension
Recruiting2 awardsPhase 3
Phoenix, Arizona
This trial is testing macitentan, a drug that helps lower lung blood pressure, in children with pulmonary arterial hypertension. Macitentan has shown significant effectiveness in improving the condition of patients with pulmonary arterial hypertension.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.